Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Not applicableStudy completedNCT04395911
What this trial is testing

Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections

Who this might be right for
AKIARDSCOVID
SeaStar Medical 22
Not applicableStudy completedNCT05076240
What this trial is testing

FilmArray® and Management of Ventilator Associated Pneumonia in COVID-19 ARDS

Who this might be right for
SARS-CoV2 InfectionVentilator Associated PneumoniaArds+1 more
Centre Hospitalier Universitaire de Nīmes 98
Large-scale testing (Phase 3)Ended earlyNCT04750278
What this trial is testing

Evaluate FP-025 in Patients With Severe to Critical COVID 19

Who this might be right for
Severe to Critical COVID 19 With Associated ARDS
Foresee Pharmaceuticals Co., Ltd. 90
Testing effectiveness (Phase 2)Ended earlyNCT04922957
What this trial is testing

A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
Covid19
Enlivex Therapeutics Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Not applicableEnded earlyNCT04397172
What this trial is testing

Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19

Who this might be right for
COVIDCorona Virus InfectionSars-CoV2
Insel Gruppe AG, University Hospital Bern 48
Not applicableStudy completedNCT05394961
What this trial is testing

Factors Associated With Decisions to Withhold or Withdraw Intensive Care

Who this might be right for
SepsisARDS, HumanCOVID-19
Uppsala University 33,256
Testing effectiveness (Phase 2)Study completedNCT04402866
What this trial is testing

TD-0903 for ALI Associated With COVID-19

Who this might be right for
Acute Lung Injury (ALI) Associated With COVID-19Lung Inflammation Associated With COVID-19
Theravance Biopharma 235
Not applicableStudy completedNCT05097677
What this trial is testing

Follow-up of Covid-19 Long Term Sequelae

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Bronchitis+15 more
Azienda Ospedaliera Universitaria Integrata Verona 7,599
Testing effectiveness (Phase 2)Looking for participantsNCT06052436
What this trial is testing

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

Who this might be right for
Systemic Inflammatory Response Syndrome
Hospital General Universitario Gregorio Marañon 24
Testing effectiveness (Phase 2)Ended earlyNCT04565249
What this trial is testing

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Who this might be right for
Acute Respiratory Distress SyndromeSARS-CoV-2
Pliant Therapeutics, Inc. 6
Not applicableStudy completedNCT04351906
What this trial is testing

Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome

Who this might be right for
ARDSHypercapnic Respiratory FailureAKI
University of Giessen 20
Not applicableStudy completedNCT07374991
What this trial is testing

Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome

Who this might be right for
COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)
University of Gaziantep 59
Testing effectiveness (Phase 2)Study completedNCT04493242
What this trial is testing

Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS

Who this might be right for
COVID-19ARDS
Direct Biologics, LLC 102
Not applicableStudy completedNCT04818164
What this trial is testing

Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusMechanical Ventilation Complication+1 more
Istanbul University - Cerrahpasa 43
Early research (Phase 1)Temporarily pausedNCT05387278
What this trial is testing

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeRespiratory Distress Syndrome
Vitti Labs, LLC 20
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Not applicableStudy completedNCT06224010
What this trial is testing

Respiratory Drive and Inspiratory Effort in COVID-19 Associated ARDS

Who this might be right for
ARDS, HumanCOVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress Syndrome+4 more
University of Turin, Italy 56
Large-scale testing (Phase 3)Study completedNCT06729593
What this trial is testing

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 87
Load More Results